167 related articles for article (PubMed ID: 37724648)
1. Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma.
Nguyen Vu TH; Kikuchi O; Ohashi S; Saito T; Ida T; Nakai Y; Cao Y; Yamamoto Y; Kondo Y; Mitani Y; Kataoka S; Kondo T; Katada C; Yamada A; Matsubara J; Muto M
Cancer Sci; 2023 Dec; 114(12):4664-4676. PubMed ID: 37724648
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma.
Ohashi S; Kikuchi O; Nakai Y; Ida T; Saito T; Kondo Y; Yamamoto Y; Mitani Y; Nguyen Vu TH; Fukuyama K; Tsukihara H; Suzuki N; Muto M
Mol Cancer Ther; 2020 Jun; 19(6):1363-1372. PubMed ID: 32371587
[TBL] [Abstract][Full Text] [Related]
3. MK1775, a selective Wee1 inhibitor, shows single-agent antitumor activity against sarcoma cells.
Kreahling JM; Gemmer JY; Reed D; Letson D; Bui M; Altiok S
Mol Cancer Ther; 2012 Jan; 11(1):174-82. PubMed ID: 22084170
[TBL] [Abstract][Full Text] [Related]
4. Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma.
Chen D; Hong R; Cao Y; Wu Q; Wang Y; Chen J; Li J; Zhang W; Zhan Q
Carcinogenesis; 2023 Aug; 44(6):451-462. PubMed ID: 37279554
[TBL] [Abstract][Full Text] [Related]
5. Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study.
Mori Y; Kikuchi O; Horimatsu T; Hara H; Hironaka S; Kojima T; Kato K; Tsushima T; Ishihara R; Mukai K; Uozumi R; Tada H; Kasai H; Kawaguchi A; Muto M
Esophagus; 2022 Jul; 19(3):444-451. PubMed ID: 35050435
[TBL] [Abstract][Full Text] [Related]
6. Cytokinetic effects of Wee1 disruption in pancreatic cancer.
Chang Q; Chandrashekhar M; Ketela T; Fedyshyn Y; Moffat J; Hedley D
Cell Cycle; 2016; 15(4):593-604. PubMed ID: 26890070
[TBL] [Abstract][Full Text] [Related]
7. USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma.
Sha B; Sun Y; Zhao S; Li M; Huang W; Li Z; Shi J; Han X; Li P; Hu T; Chen P
Cell Biol Toxicol; 2023 Oct; 39(5):2011-2032. PubMed ID: 35022897
[TBL] [Abstract][Full Text] [Related]
8. p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775.
Hauge S; Macurek L; Syljuåsen RG
Cell Cycle; 2019 Apr; 18(8):834-847. PubMed ID: 30943845
[TBL] [Abstract][Full Text] [Related]
9. WEE1 kinase inhibitor MK-1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status.
Al-Jamaei AH; de Visscher JGAM; Subramanyam VR; Forouzanfar T; Sminia P; Doulabi BZ; Helder MN
Oral Dis; 2023 Oct; 29(7):2640-2649. PubMed ID: 35672254
[TBL] [Abstract][Full Text] [Related]
10. WEE1 inhibition augments CDC7 (DDK) inhibitor-induced cell death in Ewing sarcoma by forcing premature mitotic entry and mitotic catastrophe.
Martin JC; Sims JR; Gupta A; Bakin AV; Ohm JE
Cancer Res Commun; 2022 Jun; 2(6):471-482. PubMed ID: 36338546
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the
Iannuzzi CA; Indovina P; Forte IM; Di Somma S; Malfitano AM; Bruno M; Portella G; Pentimalli F; Giordano A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33020398
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt.
Lee HH; Ye S; Li XJ; Lee KB; Park MH; Kim SM
Oncol Rep; 2014 Jan; 31(1):183-8. PubMed ID: 24247637
[TBL] [Abstract][Full Text] [Related]
16. Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress.
Cuneo KC; Morgan MA; Davis MA; Parcels LA; Parcels J; Karnak D; Ryan C; Liu N; Maybaum J; Lawrence TS
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):782-90. PubMed ID: 26975930
[TBL] [Abstract][Full Text] [Related]
17. Trifluridine Induces p53-Dependent Sustained G2 Phase Arrest with Its Massive Misincorporation into DNA and Few DNA Strand Breaks.
Matsuoka K; Iimori M; Niimi S; Tsukihara H; Watanabe S; Kiyonari S; Kiniwa M; Ando K; Tokunaga E; Saeki H; Oki E; Maehara Y; Kitao H
Mol Cancer Ther; 2015 Apr; 14(4):1004-13. PubMed ID: 25700705
[TBL] [Abstract][Full Text] [Related]
18. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
19. Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress.
Lindemann A; Patel AA; Tang L; Tanaka N; Gleber-Netto FO; Bartels MD; Wang L; McGrail DJ; Lin SY; Frank SJ; Frederick MJ; Myers JN; Osman AA
Mol Cancer Ther; 2021 Jul; 20(7):1257-1269. PubMed ID: 33947685
[TBL] [Abstract][Full Text] [Related]
20. Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines.
Nasuno T; Mimaki S; Okamoto M; Esumi H; Tsuchihara K
Cancer Sci; 2014 Feb; 105(2):202-10. PubMed ID: 24219164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
